ATRWF yields 23.53% · MRK yields 2.76%● Live data
📍 ATRWF pulled ahead of the other in Year 1
Combined, ATRWF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ATRWF + MRK for your $10,000?
Altius Renewable Royalties Corp., a renewable energy royalty company, engages in the acquisition and management of renewable energy investments and royalties in North America. It also provides tailored financing solutions to the renewable power sector. The company holds interests in a portfolio of 695 MW of wind, hydro-electric, and solar energy projects located in Texas, Kansas, and Vermont, as well as royalty interests in a portfolio of 2,845 MW of development stage wind energy projects located in Texas, Indiana, and Illinois. It serves renewable power developers, operators, and originators. The company was incorporated in 2018 and is headquartered in St. John's, Canada. Altius Renewable Royalties Corp. is a subsidiary of Altius Minerals Corporation.
Full ATRWF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.